Calchan

Developing Calcium channel blocker to treat neuropathic pain and apoptosis signal-regulating kinase 1 inhibitors.

placeLondon, England, United Kingdom calendar_todayFounded 2011 groups1 employees language calchan.co.uk

Registered entities

Innovation

3 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 139 times.

YearFilings
20151
20161
20173
20191
20201
20231

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital375%
Other / undisclosed125%
Coming soon